Interleukin Gene Polymorphisms and Breast Cancer
Author Information
Author(s): Balasubramanian SP, Azmy IAF, Higham SE, Wilson AG, Cross SS, Cox A, Brown NJ, Reed MW
Primary Institution: University of Sheffield
Hypothesis
Do specific SNPs in interleukin genes influence breast cancer susceptibility and severity?
Conclusion
Polymorphisms within key interleukin genes do not appear to play a significant overall role in breast cancer susceptibility or severity.
Supporting Evidence
- None of the polymorphisms studied showed any overall predisposition to breast cancer susceptibility.
- The results of the systematic review are summarized.
- Demographic data showed no significant differences in postmenopausal status between cases and controls.
- The study included a systematic review of previous studies on the same polymorphisms.
Takeaway
The study looked at certain genes to see if they affect breast cancer risk, but found that they don't really make a difference.
Methodology
The study involved genotyping SNPs in breast cancer patients and healthy volunteers, along with a systematic review of existing literature.
Potential Biases
The study was limited to white Caucasians, which may affect the generalizability of the results.
Limitations
The study may have missed minor associations due to sample size limitations and the control group may develop breast cancer over time.
Participant Demographics
All participants were Caucasian females, with cases being older than controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website